- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Segment 2 - Impact of the SCOTUS Decision on Genetic Testing
Dr Berger asked the panel how both the June 2013 Supreme Court decision and the Angelina Jolie disclosure impacted genetic testing and counseling. After the Supreme Court's decision there was an influx of inexpensive and more comprehensive genetic tests available.
Dr Berger asked the panel how both the June 2013 Supreme Court decision and the Angelina Jolie disclosure impacted genetic testing and counseling. After the Supreme Court’s decision there was an influx of inexpensive and more comprehensive genetic tests available. “In my view, having also been in the filed for 18 years, the entire playing field changed very, very quickly,” said Ms Matloff. “We suddenly had all of these options and we could order a lot more testing for either less money or certainly the same amount of money we were paying for BRCA analysis from Myriad, and I think this is a good and bad thing.”
Dr Brawley said that since Angelina Jolie’s disclosure, the American Cancer Society has had more inquiries regarding BRCA testing, but only BRCA testing alone. He also notes the increase of women choosing to have bilateral mastectomies even though that is not the right decision for everyone. “Many of the women who chose to get a bilateral mastectomy or are choosing to get a bilateral mastectomy, if they were to sit back, think, and understand everything about it they might chose a different method of trying to prevent breast cancer,” said Dr Brawley.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
